In a survival analysis of the responders (PR + CR), the G-CSF-positive cervical cancer patients displayed significantly shorter OS than the G-CSF-negative cervical cancer patients (OS: 24.5 months vs. 62 months, p = 0.0341) (Supplementary Figure S1A). The gene discussed is CSF3; the disease is cervical cancer.